Jin, Y., Fang, Y. and Yao, Y. (2020) “Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma"”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301607.